Loading...

DiaSorin S.p.A.

DSRLF•PNK
Healthcare
Medical - Diagnostics & Research
$71.94
$0.00(0.00%)
U.S. Market is Open • 12:05

DiaSorin S.p.A. (DSRLF) Stock Overview

Explore DiaSorin S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio17.64
EPS (TTM)$3.35
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$83.07
3 Months$79.73
1 Year Target$92.35

DSRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DiaSorin S.p.A. (DSRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.64 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
7.37%
1-Month Change
7.37%
3-Month Change
-14.03%
6-Month Change
-23.67%
Year-to-Date (YTD) Change
-5.39%
1-Year Change
-34.01%
3-Year Change
-35.77%
5-Year Change
-60.20%
All-Time (Max) Change
284.71%

Contact Information

https://diasoringroup.com
39 01 614871
Via Crescentino snc, Saluggia, VC, 13040

Company Facts

3,249 Employees
IPO DateSep 11, 2009
CountryIT
Actively Trading

Frequently Asked Questions